Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Healthy

Interventions

DRUG

Hydromorphone Hydrochloride tablet 8 mg

Hydromorphone Hydrochloride tablet 8 mg, single dose fasting

DRUG

Dilaudid® tablet 8 mg

Dilaudid® tablet 8 mg, single dose fasting

Trial Locations (1)

Gateway Medical Research, Saint Charles